SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EntreMed (ENMD)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
2135 59 0 ENMD
Emcee:  Mark Wise Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
385 Michael, Here's a press release on Genetix, first posted on the Ariad threBiomaven-4/17/1998
384 Richard, I do not know if there is any relationship to today's price actionMichael Greene-4/17/1998
383 Something up today? Closed fast up from 12 1/2 to 13 and back to 12 3/4 in lasRichard Haugland-4/17/1998
382 Angiostatin has to US patents issued, the assignee is Harvard. Endostatin is prStockDoc-4/14/1998
381 I just received the investors' packet from EntreMed. Does anyone know whetmuddphudd-4/14/1998
380 Thanks, Linaus :) Good luck! If I hear anything, I'll let you know too! Tom Caruthers-4/6/1998
379 I have no definitive explanation for the move on Friday... The stock has beenLinaus-4/5/1998
378 Any explanation for the unusual volatility on Friday? Tom Tom Caruthers-4/5/1998
377 Some info regarding endostatin production.... A recent paper in EMBO journal Linaus-4/3/1998
376 I agree with being cautious with case reports. With that in mind, are there anmuddphudd-4/3/1998
375 I don't know. One has to be careful with over interpretation of single caseStockDoc-4/3/1998
374 Here's a reprint of a Folkman Sci American article that mentions TNP-470: Biomaven-4/3/1998
373 Is TNP-470 proprietary? If so, who owns the comp. patent? Regards, JohnJohn Bloxom-4/3/1998
372 TNP-470 is a Takeda drug, no? TomTom Caruthers-4/3/1998
371 Pretty amazing report in NEJM! After 22 months of TNP-470 treatment her lung mmuddphudd-4/2/1998
370 April 2 issue of New England Journal of Medicine has a correspondence on "StockDoc-4/1/1998
369 ENMD earnings... biz.yahoo.comTom Caruthers-3/31/1998
368 Subject to the better thinking of the technical people here, my understanding iJohn Bloxom-3/31/1998
367 Great news John, as I suspected, Folkman goes for the real thing. All right. I StockDoc-3/31/1998
366 Here is some good PR!! biz.yahoo.comDavid Winkler-3/30/1998
365 What "purer" forms of the compounds would they consider? Purifying tmuddphudd-3/30/1998
364 The canine trial is underway with one animal, and that animal has a spontaneousJohn Bloxom-3/30/1998
363 I go for stepwise investment, pending on positive animal data coming out from EStockDoc-3/30/1998
362 The rodent studies took Folkman's lab more than a year to complete. They prStockDoc-3/30/1998
361 StockDoc: Given the relatively long wait, do you think this one is worth a big Sid Turtlman-3/29/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News